Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir (Avigan tablets) in novel or re-emerging influenza virus infections
jRCT1080223849Not yet recruiting
- Sponsor
- FUJIFILM Toyama Chemical
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of favipiravir in influenza, sponsored by FUJIFILM Toyama Chemical. Planned start Mar 2018; status: not yet recruiting.
02
Drugs
favipiravir
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT1080223849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223849.